Healthcare -
Biotechnology - NASDAQ - US
$ 34.63
-2.7 %
$ 2.58 B
Market Cap
-8.9
P/E
SWTX - COST OF REVENUE
Cost of Revenue SWTX - SpringWorks Therapeutics, Inc.
422 K
LAST VALUE
-7.20%
2 YEAR CAGR
89.37%
5 YEAR CAGR
0.00%
10 YEAR CAGR